Microbiome Connect: Skin EU 2021

Translating the latest skin microbiome research from clinic to the consumer

DOWNLOAD 2021 AGENDA
VIRTUAL EVENT
7-9 December, 2021

PARTNERSHIP OPPORTUNITIES: Based on your objectives, we can create bespoke packages designed specifically to meet your company’s needs. We’re dedicated to helping you showcase your services and make valuable new connections. Opportunities lie in 3 main categories: thought leadership, branding and networking. Contact us below for further information.

Why Attend

With key CPG brands launching skin microbiome focused brands over the last few years, skin microbiome is entering the mainstream of the beauty and personal care industry. The field is still in a nascent stage, but as next generation sequencing techniques and big data analysis improve, a galaxy of new information is set to be uncovered. With new regulation coming in to hold back the use of unsubstantiated claims, with high profile cases including Clariant, understanding the research and governing of this space has never been more important.

Join us this December to find out about the latest R&D and regulation that is shaping the direction for skin microbiome product development with our expert speaker faculty of key industry representatives and academics.

"An amazing event, bringing you close to industrial representatives and providing you with the opportunity to not only understand what companies are doing but also to talk with them in engage in discussion. What a great networking opportunity" - KU Leuven

Who will be there

Meet Industry Leading Experts in:

  • Independent Beauty and Personal Care Brands
  • Biotech Companies
  • Academic Researchers and Dermatologists
  • Multinational Beauty & Personal Care Brands and Multinational Pharmaceutical Companies
  • Cosmetic Formulators, Strain Manufacturers, Ingredients Suppliers, Packaging Manufacturers and Sequencing companies
  • Regulatory Experts and Consumer Trend Analysts
  • Retailers and Distributors

Skin Microbiome Past Attendees

Advisory Board

Author:

Jay Tiesman

Research Fellow - Genomics Group Leader
Proctor & Gamble

Dr. Jay Tiesman is a Principal Scientist in the Global Biotechnology Division of The Procter & Gamble Company in Cincinnati, Ohio, USA. He is the Genomics Group Leader and a Corporate Technology Entrepreneur – charged with helping to identify novel biotechnology innovations worldwide to address key needs for P&G. Since joining P&G in 1993, he has been actively involved in developing genomics capabilities within the Company. He has been particularly interested in the use of genomics to gain insight into epithelial cell biology.

Before joining P&G, he completed postdoctoral training in the laboratory of Dr. Charlie Hart at ZymoGenetics, Inc. in Seattle, Washington. At ZymoGenetics, he pursued research in the field of growth factor signal transduction associated with wound healing and tissue remodeling. He obtained his Ph.D. in Pathology from the University of Nebraska Medical Center in Omaha, Nebraska. In Omaha, he worked in the Laboratory of Dr. Angie Rizzino at the Eppley Cancer Institute, delineating the roles and impact of growth factors on embryonic development. Before joining Dr. Rizzino, he obtained Bachelor degrees in Philosophy and Biology at Creighton University in Omaha.

Dr. Tiesman was an early adopter of microarray technology, having worked in the field since 1997. He is an acknowledged microarray expert and has published over 35 articles, two of which have earned “Publication of the Year” honors. He also speaks extensively at international meetings on the topic of microarray experimental design and is listed on over 85 presentations. He collaborates extensively with scientists in academia and the biotechnology industry and is a member of several academic/governmental/industrial organizations, including the Association of Biomedical Resource Facilities Microarray Research Group (ABRF-MARG), the Association of Molecular Pathology (AMP), and the Society for Investigative Dermatology (SID); as well as the Scientific Advisory Board of NuGEN Technologies, Inc.

Jay Tiesman

Research Fellow - Genomics Group Leader
Proctor & Gamble

Dr. Jay Tiesman is a Principal Scientist in the Global Biotechnology Division of The Procter & Gamble Company in Cincinnati, Ohio, USA. He is the Genomics Group Leader and a Corporate Technology Entrepreneur – charged with helping to identify novel biotechnology innovations worldwide to address key needs for P&G. Since joining P&G in 1993, he has been actively involved in developing genomics capabilities within the Company. He has been particularly interested in the use of genomics to gain insight into epithelial cell biology.

Before joining P&G, he completed postdoctoral training in the laboratory of Dr. Charlie Hart at ZymoGenetics, Inc. in Seattle, Washington. At ZymoGenetics, he pursued research in the field of growth factor signal transduction associated with wound healing and tissue remodeling. He obtained his Ph.D. in Pathology from the University of Nebraska Medical Center in Omaha, Nebraska. In Omaha, he worked in the Laboratory of Dr. Angie Rizzino at the Eppley Cancer Institute, delineating the roles and impact of growth factors on embryonic development. Before joining Dr. Rizzino, he obtained Bachelor degrees in Philosophy and Biology at Creighton University in Omaha.

Dr. Tiesman was an early adopter of microarray technology, having worked in the field since 1997. He is an acknowledged microarray expert and has published over 35 articles, two of which have earned “Publication of the Year” honors. He also speaks extensively at international meetings on the topic of microarray experimental design and is listed on over 85 presentations. He collaborates extensively with scientists in academia and the biotechnology industry and is a member of several academic/governmental/industrial organizations, including the Association of Biomedical Resource Facilities Microarray Research Group (ABRF-MARG), the Association of Molecular Pathology (AMP), and the Society for Investigative Dermatology (SID); as well as the Scientific Advisory Board of NuGEN Technologies, Inc.

Author:

Kim Capone

Head, Microbiome Platform
Johnson & Johnson

Kim Capone

Head, Microbiome Platform
Johnson & Johnson

Author:

Sarah De Szalay

R&D Director
Stealth Health Startup

Sarah De Szalay

R&D Director
Stealth Health Startup

Author:

Larry Weiss

Chief Science and Product Officer
Symbiome

Larry Weiss

Chief Science and Product Officer
Symbiome

Author:

Trevor Steyn

CEO & Founder
Esse Organic Skincare

Trevor Steyn is the CEO and founder of Esse Skincare. As an organic chemist his research has taken a broader approach to optimising skin health in the long term. Esse launched its first live probiotic product in February 2015 and has subsequently pioneered several new technologies in modulating the skin microbiome.  

 

Trevor Steyn

CEO & Founder
Esse Organic Skincare

Trevor Steyn is the CEO and founder of Esse Skincare. As an organic chemist his research has taken a broader approach to optimising skin health in the long term. Esse launched its first live probiotic product in February 2015 and has subsequently pioneered several new technologies in modulating the skin microbiome.  

 

Author:

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.

In the context of YUN, he is closely working together with the Department of Bioscience Engineering of the University of Antwerp, the Lab of Applied Microbiology and Biotechnology of prof. Sarah Lebeer, the Lab of Pharmaceutical Technology and Biopharmacy of prof. Filip Kiekens, prof. dr. Julien Lambert (dermatology) and dr. Gilbert Donders (gynaecology, the University Hospital of Antwerp).

He has experience with leadership in multiple R&D projects and he held a managing role in YUN’s R&D projects of the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (VLAIO). YUN’s current range of probiotic products and therapies were developed under his supervision.

 

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.

In the context of YUN, he is closely working together with the Department of Bioscience Engineering of the University of Antwerp, the Lab of Applied Microbiology and Biotechnology of prof. Sarah Lebeer, the Lab of Pharmaceutical Technology and Biopharmacy of prof. Filip Kiekens, prof. dr. Julien Lambert (dermatology) and dr. Gilbert Donders (gynaecology, the University Hospital of Antwerp).

He has experience with leadership in multiple R&D projects and he held a managing role in YUN’s R&D projects of the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (VLAIO). YUN’s current range of probiotic products and therapies were developed under his supervision.

 

Author:

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

Author:

Audrey Gueniche Ph.D

HEAD OF INTERNATIONAL SCIENTIFIC VALORISATION LUXURY DIVISION
L'Oréal

Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials. Her passion is to always reinvent evaluation and find new fields of area in term of actives to promote. 

She has published over 110 papers in peer-reviewed journals, 5 chapters in books, 2 specials issues in journal where she was the invited editor. She presented in over 80 international congresses and additionally she was personally invited to give more than 35 keynote lectures.

Audrey Gueniche Ph.D

HEAD OF INTERNATIONAL SCIENTIFIC VALORISATION LUXURY DIVISION
L'Oréal

Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials. Her passion is to always reinvent evaluation and find new fields of area in term of actives to promote. 

She has published over 110 papers in peer-reviewed journals, 5 chapters in books, 2 specials issues in journal where she was the invited editor. She presented in over 80 international congresses and additionally she was personally invited to give more than 35 keynote lectures.

Author:

Erwan Peltier

Senior Medical Manager Dermatology
Bayer Consumer Care AG

Erwan Peltier

Senior Medical Manager Dermatology
Bayer Consumer Care AG

Author:

Cath O’Neill

Chief Scientific Officer
SkinBio Therapeutics

Cath O’Neill

Chief Scientific Officer
SkinBio Therapeutics

OUR 2021 PARTNERS

Gold Partner

Silver Partners

Senior Event Partner

Event Partner

OUR 2021 SPEAKER FACULTY

 

Matthew Hardman

Professor of Wound Healing
University of Hull

Matthew Hardman

Professor of Wound Healing
University of Hull

Matthew Hardman

Professor of Wound Healing
University of Hull
 

Edith Hessel

CSO
Eligo Bioscience

Edith Hessel

CSO
Eligo Bioscience

Edith Hessel

CSO
Eligo Bioscience
 

Dr Gregory Gloor

Professor of Biochemistry
University of Western Ontario

Dr Gregory Gloor

Professor of Biochemistry
University of Western Ontario

Dr Gregory Gloor

Professor of Biochemistry
University of Western Ontario
 

Soeren Kjaerulff phd

CEO
Lactobio

Soeren Kjaerulff phd

CEO
Lactobio

Soeren Kjaerulff phd

CEO
Lactobio
 

Dr Joey Shepherd

Senior Lecturer, Microbiology
University of Sheffield

Dr Joey Shepherd

Senior Lecturer, Microbiology
University of Sheffield

Dr Joey Shepherd

Senior Lecturer, Microbiology
University of Sheffield
 

Larry Weiss

Chief Science and Product Officer
Symbiome

Larry Weiss

Chief Science and Product Officer
Symbiome

Larry Weiss

Chief Science and Product Officer
Symbiome
 

Dr Julie Thornton

Professor of Cutaneous BiologyProfessor of Cutaneous Biology
University of Bradford

Dr Julie Thornton

Professor of Cutaneous BiologyProfessor of Cutaneous Biology
University of Bradford

Dr Julie Thornton

Professor of Cutaneous BiologyProfessor of Cutaneous Biology
University of Bradford
 

Carla Oates

Founder
The Beauty Chef

Carla Oates

Founder
The Beauty Chef

Carla Oates

Founder
The Beauty Chef
 

Geoff Briggs

Technology Scout
Wallgreens Boots Alliance

Geoff Briggs

Technology Scout
Wallgreens Boots Alliance

Geoff Briggs

Technology Scout
Wallgreens Boots Alliance
 

Trevor Steyn

CEO & Founder
Esse Organic Skincare

Trevor Steyn is the CEO and founder of Esse Skincare. As an organic chemist his research has taken a broader approach to optimising skin health in the long term. Esse launched its first live probiotic product in February 2015 and has subsequently pioneered several new technologies in modulating the skin microbiome.  

 

Trevor Steyn

CEO & Founder
Esse Organic Skincare

Trevor Steyn

CEO & Founder
Esse Organic Skincare

Trevor Steyn is the CEO and founder of Esse Skincare. As an organic chemist his research has taken a broader approach to optimising skin health in the long term. Esse launched its first live probiotic product in February 2015 and has subsequently pioneered several new technologies in modulating the skin microbiome.  

 

 

Assaf Oron

Chief Business Officer
Biomx

Assaf Oron

Chief Business Officer
Biomx

Assaf Oron

Chief Business Officer
Biomx
 

Elsa Jungman

Founder
ELSI Skin Health

Dr. Elsa Jungman has a Ph.D. in Skin Delivery and began her career working in Research and Development for L’Oreal in Paris. In 2015 she moved to San Francisco and has worked with several biotech and skincare companies such as AOBiome. She is an expert for the Clean Beauty Council at Credo Beauty and mentors/consults with local small companies. Today, she is the founder and CEO of ELSI Skin Health, a science-backed and clean skincare startup.

Elsa Jungman

Founder
ELSI Skin Health

Elsa Jungman

Founder
ELSI Skin Health

Dr. Elsa Jungman has a Ph.D. in Skin Delivery and began her career working in Research and Development for L’Oreal in Paris. In 2015 she moved to San Francisco and has worked with several biotech and skincare companies such as AOBiome. She is an expert for the Clean Beauty Council at Credo Beauty and mentors/consults with local small companies. Today, she is the founder and CEO of ELSI Skin Health, a science-backed and clean skincare startup.

 

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

 

Dr Cath O'Neill

Chief Scientific Officer
SkinBioTherapeutics

Dr Cath O'Neill

Chief Scientific Officer
SkinBioTherapeutics

Dr Cath O'Neill

Chief Scientific Officer
SkinBioTherapeutics
 

Audrey Gueniche Ph.D

HEAD OF INTERNATIONAL SCIENTIFIC VALORISATION LUXURY DIVISION
L'Oréal

Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials.

Audrey Gueniche Ph.D

HEAD OF INTERNATIONAL SCIENTIFIC VALORISATION LUXURY DIVISION
L'Oréal

Audrey Gueniche Ph.D

HEAD OF INTERNATIONAL SCIENTIFIC VALORISATION LUXURY DIVISION
L'Oréal

Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials. Her passion is to always reinvent evaluation and find new fields of area in term of actives to promote. 

She has published over 110 papers in peer-reviewed journals, 5 chapters in books, 2 specials issues in journal where she was the invited editor. She presented in over 80 international congresses and additionally she was personally invited to give more than 35 keynote lectures.

 

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.

In the context of YUN, he is closely working together with the Department of Bioscience Engineering of the University of Antwerp, the Lab of Applied Microbiology and Biotechnology of prof. Sarah Lebeer, the Lab of Pharmaceutical Technology and Biopharmacy of prof. Filip Kiekens, prof. dr. Julien Lambert (dermatology) and dr. Gilbert Donders (gynaecology, the University Hospital of Antwerp).

He has experience with leadership in multiple R&D projects and he held a managing role in YUN’s R&D projects of the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (VLAIO). YUN’s current range of probiotic products and therapies were developed under his supervision.

 

 

Marie Drago

Founder
Gallinée

Marie Drago is a Doctor in Pharmacy and the founder of Gallinee. Launched in 2016 in London, the brand has been caring for the skin and its microbiome though innovative products across a number of categories.

Marie Drago

Founder
Gallinée

Marie Drago

Founder
Gallinée

Marie Drago is a Doctor in Pharmacy and the founder of Gallinee. Launched in 2016 in London, the brand has been caring for the skin and its microbiome though innovative products across a number of categories.

 

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard completed his PhD in synthetic biology, working together in collaboration with the pharmaceutical industry to engineer bacteria as a living pill. He is a scientific co-founder of S-Biomedic, and is leading the research and product development. 

His passion is understanding the complex interplay of the bacterial communities that live within and on us. He is fascinated by the untouched potential of active compounds that are naturally produced everyday right on our own skin.

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard completed his PhD in synthetic biology, working together in collaboration with the pharmaceutical industry to engineer bacteria as a living pill. He is a scientific co-founder of S-Biomedic, and is leading the research and product development. 

His passion is understanding the complex interplay of the bacterial communities that live within and on us. He is fascinated by the untouched potential of active compounds that are naturally produced everyday right on our own skin.

 

Tom Dawson

Senior Principal Investigator
A* Agency for Science Technology and Research

Tom Dawson

Senior Principal Investigator
A* Agency for Science Technology and Research

Tom Dawson

Senior Principal Investigator
A* Agency for Science Technology and Research
 

Niels Verhulst

Senior Researcher
University of Zürich

Niels acquired his PhD at Wageningen University, The Netherlands and is now a senior researcher at the University of Zürich leading a group of scientists working on the behavioural ecology of mosquitoes.  

He studies how skin microbial volatiles influence the attractiveness of humans and animals to mosquitoes. His goal is to develop novel skin bacterial based products that can reduce mosquito bites and thereby pathogen transmission.

Niels Verhulst

Senior Researcher
University of Zürich

Niels Verhulst

Senior Researcher
University of Zürich

Niels acquired his PhD at Wageningen University, The Netherlands and is now a senior researcher at the University of Zürich leading a group of scientists working on the behavioural ecology of mosquitoes.  

He studies how skin microbial volatiles influence the attractiveness of humans and animals to mosquitoes. His goal is to develop novel skin bacterial based products that can reduce mosquito bites and thereby pathogen transmission.

 

Hasti Nazem

Head of Product and Education
Kindra

Hasti is part of the founding team of Kindra, leading product development and education. Kindra is developing innovative estrogen-free solutions targeting the top pain points of the 34+ symptoms of menopause. With nearly 10 years of experience at the intersection of life sciences, health and wellness, and consumer brand building, Hasti integrates targeted product formulation development with cutting edge technical advancements. Her deep scientific communications experience helps to empower consumers to better understand their health, and bridge gaps often overlooked in women's health.

Hasti Nazem

Head of Product and Education
Kindra

Hasti Nazem

Head of Product and Education
Kindra

Hasti is part of the founding team of Kindra, leading product development and education. Kindra is developing innovative estrogen-free solutions targeting the top pain points of the 34+ symptoms of menopause. With nearly 10 years of experience at the intersection of life sciences, health and wellness, and consumer brand building, Hasti integrates targeted product formulation development with cutting edge technical advancements. Her deep scientific communications experience helps to empower consumers to better understand their health, and bridge gaps often overlooked in women's health. Hasti's work has been featured in has been featured in The New York Times, Forbes.com, (O) Oprah Magazine, Harper's Bazaar, Women's Health Magazine, and in healthcare public affairs and pharmaceutical trade association publications.

 

Erwan Peltier

Senior Medical Manager Dermatology
Bayer Consumer Care AG

Erwan Peltier

Senior Medical Manager Dermatology
Bayer Consumer Care AG

Erwan Peltier

Senior Medical Manager Dermatology
Bayer Consumer Care AG
 

Sarah De Szalay

R&D Director
Stealth Health Startup

Sarah De Szalay

R&D Director
Stealth Health Startup

Sarah De Szalay

R&D Director
Stealth Health Startup
 

David Caballero-Lima

Head of R&D
Labskin

David received his undergraduate degree in Biology and his PhD in Biomedical Sciences from the Universidad de Extremadura in Spain.

David Caballero-Lima

Head of R&D
Labskin

David Caballero-Lima

Head of R&D
Labskin

David received his undergraduate degree in Biology and his PhD in Biomedical Sciences from the Universidad de Extremadura in Spain. David took postdoctoral research positions at the University of Sheffield and the University of Manchester, with both roles focusing on studying human/pathogen interaction  via tissue models and obtaining a greater understanding in the regulation of the  cell cycle and  vesicle transportation during morphological changes.  In addition he was involved in the development of point-of-care diagnostic devices for diseases such as fungal and bacterial keratitis and novel antifungal discovery.  

David was initially Services Manager at Labskin, responsible for all microbiology work and service projects, bringing his 18 years’ experience working with microbiology and host-pathogen interactions. 

As Head of R&D, David now leads the research department, focusing on the development of new methods for studying the native skin microflora, prebiotic, probiotics and antimicrobial effects of ingredients and formulation for pharmaceutical and cosmeceutical studies. He is also the scientific lead for the development of Labskin new consumers service; Skin Trust Club, a new concept of personalised skin care based on the analysis of the skin microbiome.  David is a key collaborator on international research bids, as a peer with leading international experts from academia and industry.

 

Colin O'Sullivan

Chief Information Officer
Labskin

Colin O’Sullivan joined the Deepverge team as Chief Information Officer (CIO) following the acquisition of Rinocloud Ltd. Colin is responsible for creating an information technology strategy targeted at the Deepverge growth opportunities. Colin is a global, talented, results-driven Technology leader with versatile, cross-platform experience in Digital Strategy, Medical and Science Applications, Enterprise Applications, Cloud Computing, Mobile Enablement, Business Intelligence, Artificial Intelligence,  IT Operations, Customer Experience and DevOps for diverse client industries.

Colin O'Sullivan

Chief Information Officer
Labskin

Colin O'Sullivan

Chief Information Officer
Labskin

Colin O’Sullivan joined the Deepverge team as Chief Information Officer (CIO) following the acquisition of Rinocloud Ltd. Colin is responsible for creating an information technology strategy targeted at the Deepverge growth opportunities. Colin is a global, talented, results-driven Technology leader with versatile, cross-platform experience in Digital Strategy, Medical and Science Applications, Enterprise Applications, Cloud Computing, Mobile Enablement, Business Intelligence, Artificial Intelligence,  IT Operations, Customer Experience and DevOps for diverse client industries.

Colin earned a Bachelor of Science degree at Cork Institute of Technology. As an undergraduate Colin demonstrated his early passion for technology with the winning of web design awards while leading his own digital agency Keynet Ltd. Colin went on to earn a Master of Science degree at Trinity College Dublin specialising in Ubiquitous Computing and Distributed Systems.

Colin relocated to Sydney Australia to take up strategic technology roles with responsibilities across the Asia Pacific region in a wide number of industries including Medical, Travel, Education and Science.

More recently as the Group Chief Information Officer at the Australian Medical Association (AMA)  Colin developed the technology strategy for both the membership organisation, publishing and commercial subsidiaries across Australia. Returning to Ireland from Australia Colin took up the role of Chief Information Officer at Rinocloud Ltd. Colin was responsible for development of the new product strategies with a focus on scientific data Artificial Intelligence (AI) platforms. With over a decade of experience in Executive Management roles across the globe and over 20 years experience delivering innovative technology solutions Colin has now brought his skills to the Deepverge Senior Management team.

 

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

Tuval Ben-Yehezkel is a scientist-entrepreneur focused on applied genomics and synthetic biology. Authored key patents, publications and book chapters in synthetic biology and genomics. Founded and secured $15.3M in funding for two biotech start-up companies.

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

Tuval Ben-Yehezkel is a scientist-entrepreneur focused on applied genomics and synthetic biology. Authored key patents, publications and book chapters in synthetic biology and genomics. Founded and secured $15.3M in funding for two biotech start-up companies.

Agenda

We're thrilled to share the programme for the 6th Annual Microbiome Connect: Skin Europe with you and couldn't be more excited to welcome you back face-to-face in Amsterdam this December! Download the agenda on the right hand side to find out more.

Here’s a sneak peek of some key takeaways:

  • Hear from the leading experts in the microbiome field to further understand their pipelines and clinical data
  • Learn about regulatory pathways to develop commercially viable products in the skin microbiome space
  • Discover and apply the newest techniques in personalisation of microbiome skincare, with focuses on data collection and sampling
  • Uncover the most innovative technological advances across a range of areas, including AI and sequencing for use in R&D translation
  • As ingestibles become an increasing feature of microbiome care, learn about the newest developments and research from experts in the field for further portfolio expansion
  • Identify key modalities for limiting the impact of dysbiosis through phage, LBP, prebiotics and more

To get an idea what a face-to-face conference with us looks like, check out a video of what we were up to in previous years.

Download Agenda

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Ticket price will increase in

Multinationals, Pharma, Beauty & Personal Care Companies
€899
VIRTUAL Standard Pricing
Preparing registration...

Resources

Download Resource

Partner With Us

Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.

To discuss your objectives and partnership opportunities please contact [email protected].

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Other events you might be interested in:

Microbiome Connect: Europe 2023